Is osimertinib effective as 2nd line treatment in T790M-negative EGFR mutant NSCLC?Panagiota Economopoulou,Ioannis Kotsantis,Amanda PsyrriAME Clinical Trials Review(2024)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要